Possible agent for COVID-19 treatment: Rifampicin
Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent studies. studies can serve as a foundation for further studies.
Saved in:
Published in | World journal of virology Vol. 11; no. 5; pp. 391 - 393 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
25.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!